Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Personalized Medicine Coalition Elects New Board Member

Published: Friday, June 21, 2013
Last Updated: Friday, June 21, 2013
Bookmark and Share
Patrick J. Balthrop was elected to the Coalition's board of directors.

The Personalized Medicine Coalition (PMC) has announced that Patrick J. Balthrop, president and CEO of Luminex Corporation was elected to the Coalition's board of directors for a three-year term.

"Pat will be a strong addition to the Coalition. As CEO of Luminex, an important player in the field of personalized medicine, his company has been on the forefront of developing innovative products that assist patients, including instruments and assays that make health care faster, more accurate and affordable. His leadership, notably in navigating the regulatory arena, will serve PMC well," said Stafford O'Kelly, former president of Abbott Molecular and current chairman of the PMC.

Mr. Balthrop joined Luminex Corporation as President and CEO in May of 2004. Prior to joining Luminex, Mr. Balthrop was employed by Fisher Scientific International as President of Fisher Healthcare for two years.

He spent 20 years in the medical devices and diagnostics divisions at Abbott Laboratories, successfully transforming several businesses and franchises.

His product development career achievements include the introduction of the world's first blood test for HIV and leading the development of the most widely used immunoassay assay testing system.

"I strongly believe personalized medicine has the potential to improve patient care and am honored to serve on the Coalition's board. I am committed to working with its members on public policy issues to encourage its development," said Mr. Balthrop.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PMC to Recognize NIH Director with Leadership in Personalized Medicine Award
Dr. Francis S. Collins to accept award, deliver comments during 11th Annual Personalized Medicine Conference at Harvard Medical School.
Friday, August 28, 2015
PMC Board Continues to Cultivate Leadership from Across Health Care System
Appointments afford additional representation for both diagnostic, therapeutic communities.
Saturday, June 06, 2015
PMC Applauds Margaret Hamburg's Commitment to Personalized Medicine
Hamburg's announced resignation follows the agency's most productive year for personalized medicine novel new drug approvals.
Friday, February 06, 2015
PMC Recognizes Mark Levin with Award for Leadership
Award to be presented November 12, 2014 highlights lifelong personalized medicine vision.
Wednesday, September 17, 2014
Personalized Medicine Coalition Announces Two New Board Members
Appointments deepen expertise in drug development, payer community.
Thursday, December 12, 2013
PMC Urges FDA to Clarify Rules for Drug-Diagnostic Combinations
PMC urges the agency to clarify its requirements for approving drug-diagnostic combinations.
Thursday, December 24, 2009
Personalized Medicine Coalition Publishes the Case for Personalized Medicine
The 2nd edition of PMC’s landmark report provides a comprehensive overview and analysis of the state of personalized medicine.
Thursday, May 21, 2009
HHS Secretary Leavitt Receives Personalized Medicine Coalition Award for Leadership
The annual PMC award recognizes the contributions of Secretary Leavitt in advancing the frontier of personalized medicine.
Wednesday, November 12, 2008
Personalized Medicine Coalition Applauds New Report
A new report by a presidential advisory council says that personalized medicine—treatment based on an understanding of each patient’s unique physical makeup, including genetic structure—could significantly improve healthcare.
Wednesday, October 15, 2008
PMC Endorses Democratic and Republican Positions on Personalized Medicine
PMC has applauded statements issued by both parties’ campaigns endorsing the principles of personalized medicine and its role in improving healthcare.
Tuesday, September 16, 2008
Personalized Medicine Coalition Applauds Senate Approval of the Genetic Information Nondiscrimination Act
GINA will protect individuals against possible misuse of genetic information and accelerate the adoption of personalized medicine.
Friday, April 25, 2008
Dr. Ralph Snyderman Receives 2007 Leadership in Personalized Medicine Award
Dr. Snyderman, Chancellor Emeritus, Duke University, and Founder and Chairman of Proventys, receives the award for his efforts in advancing predictive and targeted therapies on a national scale.
Friday, November 30, 2007
Personalized Medicine Coalition Supports President Bush's Call to Congress to Pass the Genetic Information Nondiscrimination Act
PMC believes that all genetic information, including family history, deserves strong and enforceable protections against misuse in health insurance and employment.
Friday, January 19, 2007
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
Genetic Signature Linked to Cancer Prognosis Identified
The results of the analysis of 8,161 tissue samples could in the future help clinicians decide how best to treat a patient as well as aid the development of new targeted treatments.
NIH Commits $6.7 M to Advance DNA, RNA Sequencing Technology
"Can you believe they make DNA sequencers the size of staplers?" asked Meni Wanunu, Ph.D. "Ideas that were crazy twenty years ago are now happening!"
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Curcumin Shows Promise as Cancer Treatment
When delivered at the correct circadian phase, curcumin demonstrates sustained toxicity in cancer cells and should be considered for use in patient care.
"Junk" DNA Critical for Heart Function
Loss of noncoding elements of genome, known as enhancers, results in abnormalities of heart functions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos